Your browser doesn't support javascript.
loading
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.
van den Berg, Eline H; Gruppen, Eke G; James, Richard W; Bakker, Stephan J L; Dullaart, Robin P F.
Afiliação
  • van den Berg EH; Departments of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Gruppen EG; Departments of Gastroenterology and Hepatology University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • James RW; Departments of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Bakker SJL; Departments of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Dullaart RPF; Departments of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J Lipid Res ; 60(1): 168-175, 2019 01.
Article em En | MEDLINE | ID: mdl-30455362
Nonalcoholic fatty liver disease (NAFLD) is characterized by low HDL cholesterol, but the activity of the HDL-associated antioxidative enzyme paraoxonase-1 (PON-1) remains unclear. To determine the association of PON-1 with suspected NAFLD, we measured serum enzyme activity in 7,622 participants of the Prevention of Renal and Vascular End-Stage Disease cohort. A fatty liver index (FLI) ≥60, a proxy of NAFLD, was present in 2,083 participants (27.3%) and coincided with increased prevalence of T2D, metabolic syndrome (MetS), (central) obesity, elevated triglycerides, and low HDL cholesterol (all P < 0.001). In men and women combined, serum PON-1 activity did not vary according to elevated FLI (P = 0.98), whereas in men with elevated FLI PON-1 activity was increased (P = 0.016). In multivariable linear regression analyses (adjusted for age, sex, T2D, MetS, alcohol use, and smoking), PON-1 activity was unexpectedly associated with elevated FLI (ß = 0.083; P < 0.001). In a sensitivity analysis (n = 5,126) that excluded subjects with positive cardiovascular history, impaired estimated glomerular filtration rate, elevated urinary albumin excretion, and drug use, PON-1 activity was also independently associated with elevated FLI (ß = 0.045; P = 0.017). These results indicate that PON-1 is paradoxically maintained and may even be increased in NAFLD despite inverse associations with metabolic disorders and low HDL cholesterol.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arildialquilfosfatase / Hepatopatia Gordurosa não Alcoólica / HDL-Colesterol Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Arildialquilfosfatase / Hepatopatia Gordurosa não Alcoólica / HDL-Colesterol Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article